Cargando…

Phthalocyanines : medical aspects of porphyrins /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Kadish, Karl M., 1945-, Smith, Kevin M., Guilard, Roger
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Academic Press, 2003.
Colección:The porphyrin handbook ; v. 14
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 SCIDIR_ocn815470914
003 OCoLC
005 20231117044748.0
006 m o d
007 cr cn|||||||||
008 121005s2003 ne a ob 001 0 eng d
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCO  |d OPELS  |d N$T  |d OCLCF  |d COO  |d YDXCP  |d EBLCP  |d MHW  |d UKDOC  |d DEBSZ  |d OCLCQ  |d LEAUB  |d OCLCQ  |d VLY  |d OCLCO  |d OCLCQ 
019 |a 843638008  |a 850149346  |a 905494980  |a 1162251494 
020 |a 9780080923888  |q (electronic bk.) 
020 |a 0080923887  |q (electronic bk.) 
020 |z 0123932246 
020 |z 9780123932242 
020 |a 9786613931917 
020 |a 6613931918 
020 |a 1283619466 
020 |a 9781283619462 
020 |a 9786613931993 
020 |a 6613931993 
020 |a 1283619547 
020 |a 9781283619547 
020 |a 0080923852 
020 |a 9780080923857 
020 |a 9786613931948 
020 |a 6613931942 
020 |a 1283619490 
020 |a 9781283619493 
035 |a (OCoLC)815470914  |z (OCoLC)843638008  |z (OCoLC)850149346  |z (OCoLC)905494980  |z (OCoLC)1162251494 
050 4 |a QD441  |b .P48 2003eb 
072 7 |a SCI  |x 013040  |2 bisacsh 
082 0 4 |a 547/.869  |2 23 
245 0 0 |a Phthalocyanines :  |b medical aspects of porphyrins /  |c editors Karl M. Kadish, Kevin M. Smith, Roger Guilard. 
260 |a Amsterdam :  |b Academic Press,  |c 2003. 
300 |a 1 online resource (xl, 347 pages :) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a The porphyrin handbook ;  |v v. 14 
504 |a Includes bibliographical references and index. 
505 0 |a Front Cover; The Porphyrin Handbook: Medical Aspects of Porphyrins; Copyright Page; Table of Contents; Preface; Chapter 85. Erythropoietic Disorders Involving Heme Biosynthesis; I. Introduction; II. Sideroblastic Anemias; III. Lead Poisoning; IV. Porphyrias; V. Iron-Deficient Erythropoiesis; VI. Animal Models; References; Chapter 86. Acute Intermittent Porphyria: From Clinical to Molecular Aspects; I. Introduction and Classification of Human Porphyrias; II. Acute Intermittent Porphyria; III. Treatment of Acute Attacks; IV. Summary; References; Chapter 87. Congenital Erythropoietic Porphyria. 
505 8 |a I. IntroductionII. Clinical Findings in CEP; III. Enzymology and Biochemical Findings; IV. Molecular Biology and Pathology; V. Physiopathology; VI. Diagnosis; VII. Treatment; References; Chapter 88. Porphyria Cutanea Tarda and Related Disorders; I. Introduction; II. The Human UROD Locus; III. Human Uroporphyrinogen Decarboxylase (UROD); IV. Molecular Pathology and Classification of UROD Deficiency Disorders; V. Porphyria Cutanea Tarda; VI. Hepatoerythropoietic Porphyria; References; Chapter 89. Variegate Porphyria; I. Introduction; II. History and Prevalence. 
505 8 |a III. Heme Biosynthetic Enzymes in Variegate Porphyria (VP)IV. Diagnosis of VP; V. Clinical Features of VP; VI. Homozygous VP; VII. Conclusion; References; Chapter 90. Protoporphyria; I. Protoporphyria; II. Definition and History; III. Prevalence of Protoporphyria; IV. Clinical Features; V. Pathological Features of Protoporphyria; VI. Biochemical Abnormalities; VII. Pathogenesis; VIII. Clinical and Molecular Genetics of Protoporphyria; IX. Diagnosis of Protoporphyria; X. Treatment; XI. Future Directions in Protoporphyria Research; XII. Summary; References. 
505 8 |a Chapter 91. Miscellaneous Abnormalities in Porphyrin Production and DisposalI. Introduction; II. Porphyrin Excretion in Bile and Urine; III. Secondary Porphyrinopathies; IV. The Bronze Baby Syndrome; V. The Multiple Chemical Sensitivity Syndrome; VI. Porphyrin Abnormalities in Response to Lead and Other Industrial Toxins; VII. Pseudoporphyria; VIII. Disturbances in Porphyrin Metabolism and Excretion Associated with Renal Disease; IX. Porphyrin Disturbances in Carcinomatosis; X. Familial Conjugated Hyperbilirubinaemias; References. 
505 8 |a Chapter 92. Porphyria Caused by Chlorinated AH Receptor Ligands and Associated Mechanisms of Liver InjuryI. Introduction; II. Known Porphyrogenic Polyhalogenated Aromatic Chemicals; III. Porphyria and Porphyrinuria in Man; IV. Experimental Porphyria in Animals by Polyhalogenated Aromatic Chemical; V. Metabolic Responses; VI. Mechanistic Hypotheses of Uroporphyria; VII. Liver Injury and Cancer Associated with Porphyria; VIII. Summary; References; Chapter 93. Porphyria: A Diagnostic Approach; I. Introduction; II. Approach to the Diagnosis of the Porphyrias. 
546 |a English. 
650 0 |a Phthalocyanines. 
650 0 |a Porphyrins. 
650 6 |a Phtalocyanines.  |0 (CaQQLa)201-0049014 
650 6 |a Porphyrines.  |0 (CaQQLa)201-0049015 
650 7 |a SCIENCE  |x Chemistry  |x Organic.  |2 bisacsh 
650 7 |a Phthalocyanines.  |2 fast  |0 (OCoLC)fst01062248 
650 7 |a Porphyrins.  |2 fast  |0 (OCoLC)fst01071936 
700 1 |a Kadish, Karl M.,  |d 1945- 
700 1 |a Smith, Kevin M. 
700 1 |a Guilard, Roger. 
776 0 8 |i Print version:  |a Kadish, Karl.  |t Porphyrin Handbook : Medical Aspects of Porphyrins.  |d Burlington : Elsevier Science, �2006  |z 9780123932242 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780080923888  |z Texto completo